Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 admin Website Related Posts Nebius Shares Soar on US$17.4 Billion Microsoft AI Deal September 10, 2025 How to Invest in Medical Device Stocks and ETFs September 10, 2025 Gold and Silver Stocks Dominate TSX30 List of Top Performers September 10, 2025